<p>Clinical breakpoints of MICs for the antimicrobial agents see the reference <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0111491#pone.0111491-CLSI1" target="_blank">[25]</a>.</p><p>The susceptibility for strains of <i>E. coli</i> J53Az<sup>R</sup>, Kp1241, Kp1769, and transconjugants (J53Az<sup>R</sup>-Kp1241 and J53Az<sup>R</sup>-Kp1769).</p
<p>MIC distribution of 500 <i>E. coli</i> isolates (in %) tested for their antimicrobial susceptibil...
International audienceObjectives A previous study identified an association between high MICs of qua...
Objectives: As part of the multicentre Antibiotic Therapy Optimisation Study, MIC values of 19 non-b...
<p>MIC: Minimum inhibitory concentration, CTX: cefotaxime, CAZ: ceftazidime, FEP: cefepime, FOX: cef...
<p>Note: MIC = minimum inhibitory concentration, R = resistant, S = susceptible, I = intermedi...
This study was designed to determine the in vitro activities of several antimicrobial agents against...
a<p>Breakpoints are based on the CLSI standards for <i>V. cholerae</i>.</p>b<p>Other breakpoints ref...
Sixteen antimicrobial agents were tested in the Sensititre™ panel to evaluate the antimicrobial susc...
<p>Antibacterial susceptibility of various Multidrug resistant (MDR) <i>E. aerogenes</i> clinical is...
<p>Antimicrobial susceptibility profiles and sequence types (ST) of clinical <i>E</i>. <i>coli</i> i...
<p>S, susceptible, the diameter of inhibition zone ≥17 mm; I, intermediate, the diameter of inhibiti...
<p>(A) <i>E</i>. <i>coli</i> 774.1 (reference antibiotic cefotaxime). <i>E</i>. <i>coli</i> antibiot...
Antibiotic susceptibility of the donor EC2189, transconjugant TcEC2189 and recipient C600 strains.</...
Antimicrobial susceptibility pattern for E. coli (n = 12) and K. pneumoniae (25) isolates on selecti...
WOS: 000464106600008Objective: Our aim in this study is to compare the Clinical Laboratory Standards...
<p>MIC distribution of 500 <i>E. coli</i> isolates (in %) tested for their antimicrobial susceptibil...
International audienceObjectives A previous study identified an association between high MICs of qua...
Objectives: As part of the multicentre Antibiotic Therapy Optimisation Study, MIC values of 19 non-b...
<p>MIC: Minimum inhibitory concentration, CTX: cefotaxime, CAZ: ceftazidime, FEP: cefepime, FOX: cef...
<p>Note: MIC = minimum inhibitory concentration, R = resistant, S = susceptible, I = intermedi...
This study was designed to determine the in vitro activities of several antimicrobial agents against...
a<p>Breakpoints are based on the CLSI standards for <i>V. cholerae</i>.</p>b<p>Other breakpoints ref...
Sixteen antimicrobial agents were tested in the Sensititre™ panel to evaluate the antimicrobial susc...
<p>Antibacterial susceptibility of various Multidrug resistant (MDR) <i>E. aerogenes</i> clinical is...
<p>Antimicrobial susceptibility profiles and sequence types (ST) of clinical <i>E</i>. <i>coli</i> i...
<p>S, susceptible, the diameter of inhibition zone ≥17 mm; I, intermediate, the diameter of inhibiti...
<p>(A) <i>E</i>. <i>coli</i> 774.1 (reference antibiotic cefotaxime). <i>E</i>. <i>coli</i> antibiot...
Antibiotic susceptibility of the donor EC2189, transconjugant TcEC2189 and recipient C600 strains.</...
Antimicrobial susceptibility pattern for E. coli (n = 12) and K. pneumoniae (25) isolates on selecti...
WOS: 000464106600008Objective: Our aim in this study is to compare the Clinical Laboratory Standards...
<p>MIC distribution of 500 <i>E. coli</i> isolates (in %) tested for their antimicrobial susceptibil...
International audienceObjectives A previous study identified an association between high MICs of qua...
Objectives: As part of the multicentre Antibiotic Therapy Optimisation Study, MIC values of 19 non-b...